Daily Bulletin

Men's Weekly

.

Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression

SYDNEY, Jan. 30, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, today announced compelling preclinical and...

Read more: Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1...

Business News

Automotive Expert, Raffy Sgroi, Warns: Australia is Building Snowflakes in the Desert with EV Policy

With the National Electric Vehicle Strategy due for a comprehensive review during 2026, automotive expert and senior government advisor, Raffy Sgroi, warns that Australia is rushing electric vehic...

Daily Bulletin - avatar Daily Bulletin

China Gold Coin Group Launched 2026 Chinese Dragon Silver Bullion Coin at World Money Fair in Berlin

China Gold Coin Group Co., Ltd. unveiled its 2026 Chinese Dragon Silver Bullion Coin at the World Money Fair held in Berlin, Germany, from January 29 to 31. Led by Mr Jinpu Jiao, Chairman of the Boa...

Daily Bulletin - avatar Daily Bulletin

How to Choose the Right Industrial Air Compressor for Your Business

Running a business is all about making the right decisions. When it comes to choosing an industrial air compressor, that decision becomes even more critical. Air compressors are long-term investment...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business